Genetic maps
Table 1 summarizes the main statistics of the individual genetic maps obtained for each cross.Overall, we obtained genetic map sizes coherent with their expected size according to ten high-quality maps based on flexible and scalable genotyping by sequencing (fsGBS) (Heffelfinger et al. 2014; Fragoso et al. 2017), indicating the good level of purity of the F2 populations and the high quality of the SNP data.
Segregation distortion (SD): SD was observed on chromosome 3 (11.1-21.0 Mbp) in the crosses involving WAS 208, Badka and FD 2000. This region is commonly affected by SD in indica ´ japonica crosses (Wang et al. 2009; Fragoso et al. 2017). The homozygotes for the donor allele (AA genotype) were favored over both the homozygotes for the susceptible parent allele (BB genotype) and the heterozygotes (AB). In the cross WAS 208 ´ BBT 50 cross, a pattern of SD was also observed on chromosome 8 (3.53-16.44 Mbp), where the AB genotypes were favored over the AA. In the cross PTB 25 ´ BBT 50, segregation distortion was observed on chromosomes 2 (20.1 Mbp, 47AA:50AB:11BB), 6 (2.9-7.9 Mbp, 34AA:64AB:10BB) and 9 (10.8-12.2 Mbp, 42AA:54AB:12BB).
RHBV incidence and severity variation
In the cross WAS 208 ´ BBT 50, the parental lines showed 24% and 98% of incidence and 25.8% and 69.5% of RHBV severity in WAS 208 and BBT 50, respectively. The F3 families (each representing one F2 parental plant) exhibited a continuous variation of incidence ranged between 21.4% and 100%, as well as a variation of severity ranged between 9% and 68% (Figure 2). The high incidence score for the susceptible parent BBT 50 – almost 100% – and the maximum values in the F3 families indicate a perfect infection efficiency. The similarity between the severity score for BBT 50 and the maximum scores in F3 families indicates that the experimental design, and in particular the population size, were adequate to capture the range of variation between the parental values. Interestingly, some F3 families exhibited a significant lower severity than the resistant parent WAS 208.
In the cross Badka ´ BBT 50, the resistant and susceptible parents exhibited 32.8% and 98.9% of RHBV incidence, respectively. In the same order, these parents displayed 35.3% and 82% of severity. The incidence in the F3 families ranged between 13% to 98%, and the severity varied between 11% and 80% (Figure 2). A positive correlation between incidence and severity of the disease was detected (r=0.56, p<0.0001), suggesting a common partial genetic control for both assessments of RHBV disease. Some F3 families exhibited lower incidence and severity than the resistant parent Badka.
In the cross PTB 25 x BBT 50, the incidence of the resistant and susceptible parents was 3.4% and 98.2%, respectively, and ranged between 5% to 96% in the F3 families. Furthermore, PTB 25 and BBT 50 showed 11.8% and 68% of severity, respectively. The same trait varied between 7% and 69% in the F3 families.
In the cross FD 2000 ´ BBT 50, the resistant and susceptible parents showed 20.8% and 75.4% of RHBV incidence, and 3.4% and 50.1% of severity, respectively. In the F3 families; incidence ranged between 10% and 90%, and severity between 0% and 59%. The incidence and severity for the susceptible parent BBT 50 were notably lower than in the crosses before mentioned, indicating a low infection efficiency that can affect the power of QTL detection and the QTL effects estimation. In contrast, the incidence of FD 2000 was higher than in previous works (Romero et al. 2014; Cruz-Gallego et al. 2018).
Incidence and severity showed correlation between 0.42 and 0.66 (Table 2), indicating either a common genetic control of the two traits, or that they are interdependent.
The major QTL qHBV4.1 for RHBV incidence is present in most donors
A major QTL, qHBV4.1, on chromosome 4 for RHBV incidence was identified by SMR, SIM and CIM in the crosses Badka ´ BBT 50 (LOD=20.97, R2=0.63), PTB 25 ´ BBT 50 (LOD=21.26, R2=0.60) and FD 2000 ´ BBT 50 (LOD=9.11, R2=0.34) (Table 3). It was not detected in the cross WAS 208 ´ BBT 50, although a fake QTL analysis (Lorieux 2018) showed that it could be present in WAS 208, but with a much smaller effect (data not shown). The QTL support intervals are overlapping in the three populations, suggesting that the same QTL is shared by the three resistance donors. Joint analysis gave a LOD=47.00 and R2=0.42 at the position ~3.56 Mbp. The qHBV4.1 position also corresponds to a previously identified locus characterized as the major contributor to RHBV resistance in FD 2000 and FD 50 (Romero et al., 2014), confirming the wide range of action of this QTL. It explained 34-63% of the trait variance, indicating that qHBV4.1 is a major regulating factor of incidence of RHBV infection. The estimation of QTL effects for qHBV4.1 showed that this QTL is mostly of the additive type. The same genomic region was also associated with RHBV severity in the same crosses, however with lower LOD scores and R2 values (LOD=6.69-8.50, R2=25-31%).
A new major QTL for RHBV incidence, qHBV4.2, identified in WAS 208
The control of RHBV incidence in WAS 208 was mainly explained by a different QTL on chromosome 4, designated as qHBV4.2WAS208 (LOD=15.49, R2=0.52) by SMR, SIM and CIM. This QTL was not found in the other crosses (Table 3). This newly discovered QTL was located between 21.29 and 21.81 Mbp and explained 52% of the incidence variance. qHBV4.2 is therefore another major QTL for RHBV incidence that seems less frequent than qHBV4.1 in the rice germplasm.
Two new QTLs for RHBV incidence identified in WAS 208 and PTB 25
Two additional QTLs, although of lesser effect, were detected for RHBV incidence (Table 4):
– qHBV6.1PTB25 on chromosome 6 (0.18-1.76 Mbp, LODSIM=3.64, LODCIM=9.71, R2=25%), mostly of the additive type effect and detected in the PTB 25 ´ BBT 50 cross only.
– qHBV11.2 on chromosome 11 in the crosses involving WAS 208 (7.43-11.9 Mbp, LODCIM=5.02, R2=21%) and PTB 25 (7.43-16.6 Mbp, LODCIM=5.9, R2=24.2%). However, the SMR or SIM methods produced LOD scores under the retained threshold (Tables 3 and 5).
A new QTL, qHBV11.1, controls RHBV severity
One of the most interesting results of this work is the discovery of a new QTL associated with RHBV symptoms severity (measured as ALA). It was detected on chromosome 11 in the crosses WAS 208 ´ BBT 50 (18.0-18.8 Mbp, LOD=5.32, R2=0.21), Badka ´ BBT 50 (17.8-18.5 Mbp, LOD=4.68, R2=0.19) and FD 2000 ´ BBT 50 (17.8-18.5 Mbp, LOD=8.98, R2=0.33). This QTL was designated as qHBV11.1 and explained 17-33% (SIM) or 19-37% (CIM) of the trait variation, depending on the cross (Tables 3 and 4). The QTL effects in the populations involving WAS 208 and Badka indicate an additive behavior of qHBV11.1, while in FD 2000 ´ BBT 50 it seems to be more dominant (Table 3). Due to the correlation between incidence and severity, qHBV11.1 was also significant for RHBV incidence in the cross FD 2000 ´ BBT 50 although with lower statistics (LOD=7.43, R2=0.29), confirming that this QTL is controlling primarily the RHBV severity.
The qHBV4.1 and qHBV11.1 QTLs show strong interaction
Testing interaction between QTL regions with the R/qtl “scantwo” function produced a strong signal between the two QTLs qHBV4.1 and qHBV11.1 (LOD>15)(Figure S1), revealing either an epistasis relationship between the two regions, or a simple interdependency between the two traits. This is coherent with the positive correlation observed between severity and incidence.
Joint- and meta-analyses provide good candidates for QTL cloning
The joint and meta-analyses approaches allow pooling populations, providing more resolution for QTL mapping. This allowed us identifying candidate genes that could underlie two of the QTLs we discovered.
The qHBV4.1 region contains the AGO-4 Argonaute gene
In the qHBV4.1 region, 33 genes encoding proteins with unknown function, five hypothetical genes, four genes encoding different types of kinases, two genes of the MEG (maternally expressed gene) family involved in the translocation of nutrients to the seed, and one Argonaute gene were identified. The most interesting gene within the qHBV4.1 region is probably the Argonaute AGO-4 (MSU: LOC_Os04g06770, Chr4:3,562,793-3,555,220bp). AGO proteins are effector proteins of RNA silencing pathways, which regulate gene expression in a sequence-specific manner (Duan et al. 2015). RNA silencing is also the main antiviral defense mechanism possessed by plants. It can be post-transcriptional (PTGS) or transcriptional (TGS) (Carbonell and Carrington 2015).
The qHBV11.1 region contains a gene for durable resistance to Rice stripe virus
The genomic region of qHBV11.1 contains many nucleotide binding site-leucine-rich repeat (NBS-LRR) genes, which are broadly known to confer resistance to multiple diseases (McHale et al. 2006). Other types of genes are also found in the interval, and remarkably the STV11 gene (MSU:LOC_Os11g30910, Chr11:17,984,964-17,986,719b; RAP-DB: Os11g0505300), which confers durable resistance to Rice stripe virus (RSV), one of the most devastative viral diseases of rice in Asia (Wang et al. 2014). Interestingly, this virus belongs to the same genus as RHBV and it is also transmitted by planthoppers (Laodelphax striatellus Fallen). It should be also noted that, very close to the qHBV11.1 support interval, there are several paralog histidine kinase/Hsp90-like ATPase genes (MSU:LOC_Os11g31480, MSU:LOC_Os11g31500) that also confer resistance to RSV (Hayano-Saito and Hayashi, 2020).